Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ46082 Inhibitors

FLJ46082 inhibitors are a class of chemical compounds designed to target and inhibit the activity of the FLJ46082 protein. The FLJ46082 protein, also known by its gene name or other aliases, is part of a broader family of proteins involved in various cellular processes, including regulation of gene expression and protein interactions. Inhibitors of this protein typically function by binding to specific domains within FLJ46082, disrupting its normal activity and altering its ability to interact with other molecular partners. These compounds can be highly selective, designed to bind only to FLJ46082, or they may exhibit a broader range of activity, affecting similar proteins with shared structural features. The exact mechanism of inhibition can vary depending on the inhibitor's structure, but generally, they act by blocking the active site or inducing conformational changes in FLJ46082 that prevent its normal function.

Structurally, FLJ46082 inhibitors can belong to diverse chemical classes, including small molecules, peptides, or even larger macromolecules. These inhibitors are often developed through a combination of structure-based drug design, high-throughput screening, and computational modeling techniques. The chemical modifications made to these inhibitors aim to enhance their specificity, binding affinity, and overall stability within biological environments. Key factors in the design of these inhibitors include their solubility, ability to penetrate cell membranes, and metabolic stability. Additionally, the synthesis of FLJ46082 inhibitors may involve complex chemical reactions, often requiring optimization to improve yields and reduce unwanted side products. Such compounds are vital tools for studying the biochemical pathways involving FLJ46082 and for gaining insight into its broader role in cellular physiology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A non-selective protein kinase inhibitor that can disrupt various signaling pathways by inhibiting protein kinases that could be upstream or downstream of the protein of interest.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of MEK, which acts upstream of ERK in the MAPK/ERK signaling pathway. By inhibiting MEK, it can reduce the activation of ERK and potentially influence the activity of proteins regulated by this pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A potent inhibitor of PI3K, which is a part of the PI3K/AKT signaling pathway. Inhibition of PI3K can affect various cellular processes, potentially including those that the protein of interest might be involved in.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, which could lead to similar effects as LY294002, impacting signaling pathways that may indirectly influence the protein of interest.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A selective inhibitor of p38 MAPK, which can alter inflammatory responses and cell differentiation pathways. This inhibition might affect proteins that are regulated by or interact with p38 MAPK.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A selective inhibitor of MEK, which might therefore indirectly affect proteins that are part of or regulated by the MAPK/ERK signaling pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, which can impact protein synthesis and cell growth. Proteins involved in these cellular processes could be indirectly affected by the inhibition of mTOR.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that inhibits calcineurin, thereby affecting NFAT (nuclear factor of activated T-cells) signaling. This could influence proteins that are regulated by or involved in T-cell activation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which could modify the JNK signaling pathway and thus have an impact on proteins that are regulated by or interact with JNK.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

An Aurora kinase inhibitor that could affect cell cycle progression and mitosis. By inhibiting Aurora kinases, it might influence proteins associated with these processes.